Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Sangamo Therapeutics Inc | SGMO | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.5644 | 05:25:49 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.5644 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.2911 - 1.67 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| - | 0 | US$ 0.5644 | USD |
Sangamo Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 100.19M | 178.91M | - | 176.23M | -257.83M | -1.44 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Sangamo Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SGMO Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.61 | 0.6643 | 0.53 | 0.5792685 | 1,518,416 | -0.0456 | -7.48% |
| 1 Month | 0.5535 | 0.70 | 0.49 | 0.5832335 | 2,207,262 | 0.0109 | 1.97% |
| 3 Months | 0.91 | 0.9782 | 0.46001 | 0.6218942 | 1,935,211 | -0.3456 | -37.98% |
| 6 Months | 0.4434 | 1.48 | 0.3462 | 0.7096148 | 2,024,190 | 0.121 | 27.29% |
| 1 Year | 1.19 | 1.67 | 0.2911 | 0.7820249 | 2,032,198 | -0.6256 | -52.57% |
| 3 Years | 10.80 | 12.8297 | 0.2911 | 3.33 | 1,673,084 | -10.24 | -94.77% |
| 5 Years | 8.79 | 19.43 | 0.2911 | 6.33 | 1,713,787 | -8.23 | -93.58% |
Sangamo Therapeutics Description
| Sangamo Therapeutics Inc is a clinical-stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy. The company's product pipeline includes Hemophilia, Central Nervous System, HIV, Lysosomal Storage Disorders, and Hemoglobinopathies. |
